Table 2

Clinical Details of Patients
Patient no.
 Age/sex
 Survival after stroke
 NIHSS on admission
 Hypertensiona
 Coronary artery disease
 Atrial fibrillation
 History of TIA/previous stroke
 Hypercholesterolemiab
 Smoking
 Obesityc
 Cause of death
 Antiplatelets
 Statinsd
 RSA-be
1
 63/F
 2 days
 26
 Yes
 No
 No
 No
 No
 No
 No
 Large ischemic stroke
 No
 No
 Yes
2
 84/M
 3 days
 21
 Yes
 Yes
 No
 No
 No
 Yes
 No
 Malignant stroke
 No
 No
 No
3
 68/M
 3 days
 24
 Yes
 Yes
 No
 No
 Yes
 No
 No
 Brain oedema
 No
 No
 Yes
4
 84/M
 6 days
 22
 Yes
 Yes
 No
 No
 No
 No
 No
 Cardiac failure
 Yes
 Yes
 No
5
 51/M
 9 days
 25
 Yes
 No
 No
 Yes
 No
 No
 No
 Respiratory infection
 Yes
 No
 No
6
 74/M
 15 days
 22
 Yes
 Yes
 No
 No
 No
 No
 Yes
 Heart attack
 Yes
 No
 Yes
7
 86/M
 15 days
 14
 Yes
 Yes
 No
 No
 Yes
 No
 No
 Urinary infection
 Yes
 No
 No
8
 58/M
 17 days
 16
 Yes
 Yes
 No
 No
 Yes
 Yes
 No
 Cardiac infarction
 Yes
 No
 No
9
 74/M
 20 days
 12
 Yes
 Yes
 No
 No
 No
 No
 No
 Bronchial aspiration
 Yes
 No
 No
10
 73/M
 26 days
 14
 Yes
 Yes
 No
 No
 Yes
 No
 Yes
 Respiratory infection
 Yes
 No
 Yes
11
 75/M
 29 days
 20
 No
 Yes
 Yes
 No
 No
 Yes
 No
 Septic shock
 Yes
 No
 Yes
12
 60/F
 37 days
 18
 Yes
 Yes
 No
 No
 Yes
 Yes
 No
 Pulmonary embolism
 Yes
 No
 No

a Blood pressure greater than 135/85 mmHg.

b Serum total cholesterol levels greater than 5.2 mmol.

c Body mass index greater than 30.

d Patients who were on statins before the ischemic stroke.

e Patients taking either angiotensin converting enzyme inhibitors or angiotensin type I receptor antagonists.

M = male; F = female; NIHSS = NIH Stroke Scale; TIA = Transient Ischaemic Attack.

Mitsios et al. BMC Neuroscience 2007 8:93   doi:10.1186/1471-2202-8-93